LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
- Status
- TERMINATED
- Phase
- N/A
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
- Status
- COMPLETED
- Phase
- N/A
Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
- Status
- UNKNOWN
- Phase
- N/A
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas
- Status
- COMPLETED
- Phase
- PHASE3
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
- Status
- UNKNOWN
- Phase
- N/A
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- NA
Perception Prognosis, Goals of Treatment, and Communication
- Status
- COMPLETED
- Phase
- N/A